TABLE 1.
Candida sp. (no. of isolates), azole, and method | 24 h |
48 h |
EAa (%) | ||||
---|---|---|---|---|---|---|---|
MIC range | MIC50 | MIC90 | MIC range | MIC50 | MIC90 | ||
C. albicans (84) | |||||||
Fluconazole | |||||||
VK2 | ≤1-≥64d | ≤1 | ≤1 | ||||
CLSI | <0.125-64 | 0.125 | 0.5 | <0.125->64 | 0.5 | 2 | 98.8 |
Etest | 0.094-128 | 0.25 | 0.38 | 0.094->256 | 0.625 | 2 | 89.3 |
Voriconazole | |||||||
VK2 | ≤0.12-0.5 | ≤0.12 | ≤0.12 | ||||
CLSI | <0.03-1 | 0.03 | 0.125 | <0.03-2 | 0.03 | 0.125 | 100 |
Etest | 0.003-1 | 0.008 | 0.023 | 0.002-2 | 0.02 | 0.064 | 98.8 |
C. parapsilosis (22) | |||||||
Fluconazole | |||||||
VK2 | ≤1 | ≤1 | ≤1 | ||||
CLSI | <0.125-8 | 0.125 | 0.5 | <0.125-8 | 0.25 | 0.5 | 95.4 |
Etest | 0.064-0.5 | 0.315 | 0.38 | 0.064-8 | 1 | 1.5 | 90.9 |
Voriconazole | |||||||
VK2 | ≤0.12 | ≤0.12 | ≤0.12 | ||||
CLSI | <0.03-0.25 | <0.03 | <0.03 | <0.03-0.25 | <0.03 | 0.03 | 100 |
Etest | 0.004-0.047 | 0.012 | 0.023 | 0.006-0.19 | 0.032 | 0.064 | 100 |
C. tropicalis (17) | |||||||
Fluconazole | |||||||
VK2 | ≤1-2 | ≤1 | 2 | ||||
CLSI | <0.125-2 | 0.25 | 0.5 | 0.125-2 | 0.5 | 2 | 100 |
Etest | 0.5-2 | 1.5 | 1.5 | 0.38-6 | 1.5 | 3 | 64.7 |
Voriconazole | |||||||
VK2 | ≤0.12 | ≤0.12 | ≤0.12 | ||||
CLSI | <0.03-0.06 | 0.03 | 0.06 | 0.03-0.25 | 0.06 | 0.125 | 100 |
Etest | 0.016-0.094 | 0.047 | 0.094 | 0.012-0.25 | 0.094 | 0.19 | 100 |
Other Candida spp. (5)c | |||||||
Fluconazole | |||||||
VK2 | ≤1-2 | ≤1 | ≤1 | ||||
CLSI | <0.125-0.5 | 0.125 | 0.125 | <0.125-4 | 0.125 | 0.125 | 100 |
Etest | 0.064-3 | 0.75 | 0.75 | 0.064-3 | 0.75 | 0.75 | 100 |
Voriconazole | |||||||
VK2 | ≤0.12-≤0.12 | ≤0.12 | ≤0.12 | ||||
CLSI | <0.03-<0.03 | <0.03 | <0.03 | <0.03-<0.03 | <0.003 | <0.003 | 100 |
Etest | 0.004-0.094 | 0.023 | 0.023 | 0.004-0.094 | 0.023 | 0.023 | 100 |
C. glabrata (56) | |||||||
Fluconazole | |||||||
VK2 | ≤1-≥64 | 8 | 32 | ||||
CLSI | <0.125-64 | 2 | 8 | 0.125->64 | 6 | 16 | 94.6 |
Etest | 0.094->256 | 7 | 16 | 0.094->256 | >256 | >256 | 25 |
Voriconazole | |||||||
VK2 | ≤0.12-≥8 | ≤0.12 | 2 | ||||
CLSI | <0.03-8 | 0.125 | 0.5 | 0.03-8 | 0.125 | 2 | 89.3 |
Etest | 0.016-8 | 0.125 | 1.5 | 0.032->32 | 1.5 | 32 | 32.1 |
C. inconspicua (5), C. norvegensis (2) | |||||||
Fluconazole | |||||||
VK2 | 4-≥64 | 16 | 16 | ||||
CLSI | <0.125-16 | <0.125 | <0.125 | 2-32 | 16 | 16 | 100 |
Etest | 8-24 | 10 | 10 | 24->256 | >256 | >256 | 85.7 |
Voriconazole | |||||||
VK2 | ≤0.12-0.25 | ≤0.12 | ≤0.12 | ||||
CLSI | <0.03-0.5 | <0.03 | <0.03 | 0.03-0.5 | 0.25 | 0.25 | 100 |
Etest | 0.19-2 | 0.19 | 0.19 | 0.19-2 | 0.19 | 0.19 | 85.7 |
C. krusei (14) | |||||||
Fluconazole | |||||||
VK2 | 4-32 | 16 | 32 | 100/92.8b | |||
CLSI | 0.25-64 | 16 | 32 | 8-64 | 32 | 64 | 100b |
Etest | 32->256 | >256 | >256 | ||||
Voriconazole | |||||||
VK2 | ≤0.12-0.25 | ≤0.12 | 0.25 | ||||
CLSI | 0.03-0.5 | 0.25 | 0.5 | 0.25-1 | 0.5 | 1 | 92.8 |
Etest | 0.19-0.5 | 0.25 | 0.25 | 0.064-1.5 | 0.25 | 1.5 | 64.3 |
EA between VK2 and the two other methods at 48 h.
EA calculated with Vitek 2 expert software interpretive values.
C. lusitaniae (n = 2), C. guilliermondii (n = 1), C. kefyr (n = 1), and C. dubliniensis (n = 1).
MICs are in micrograms per milliliter.